News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Jeff Bercovici, Inc. | 08.01.2016
Untitled Document

More than anything, Peter Thiel, the billionaire technology investor and Donald Trump supporter, wants to find a...

By Malcolm Ritter, Associated Press | 08.01.2016
Untitled Document

NEW YORK — In a key advance for the study of depression, a comprehensive scan of human DNA...

By David Jensen, California Stem Cell Report | 07.31.2016
Untitled Document The New York Times this weekend unveiled a dramatic, special report on immunotherapy to treat cancer, a field...
Flag
By The Nation [Thailand], The Nation [Thailand] | 07.31.2016

SOME Thai 35 couples used surrogates to get children - including three Thai women married to spouses from Britain, Russia

...
By Celine Cooper, Montreal Gazette | 07.31.2016
Untitled Document

As first reported in La Presse last week, a Quebec court recently handed down a decision in which...

By Angus Chen, NPR | 07.30.2016
Untitled Document

There are apps that can help people with diabetes keep track of their blood sugar and apps that...

By Nhan Dan, Vietnam Net Bridge | 07.29.2016
Untitled Document

According to Director of Hue Central Hospital Prof. Dr. Bui Duc Phu, this is among the first three...

By Ben Adams, Fierce Biotech | 07.28.2016

Gene editing biotech Editas Medicine ($EDIT) has signed a three-year R&D collab deal with Milan-based San Raffaele Telethon Institute for...